Additional file 1 of Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis

Additional file 1: Supplementary 1. Methodology details: secondary outcomes definition, study risk of bias and confidence in the evidence assessments. Supplementary 2. Characteristics of included studies table and references. Supplementary 3. Risk of bias summary table. Supplementary 4. Table of ongoing studies (last update December 2020). Supplementary 5. Network plots of evidence for secondary outcomes. Supplementary 6. Results of the pairwise meta-analyses for primary and secondary outcomes. Supplementary 7. Assessment of the confidence in the network estimates of each drug versus placebo/no treatment and versus aspirin ≤150 mg/day by outcome. Supplementary 8. SUCRA, probability to be the best and mean rank by outcome. Supplementary 9. Results from the assessment of incoherence by using global and local (side-split method) approaches for primary and secondary outcomes. Supplementary 10. Comparison-adjusted funnel plot for a network of interventions by outcome.